Drug Type Small molecule drug |
Synonyms Deuterium-modified atazanavir, CTP 518 |
Target |
Mechanism HIV-1 protease inhibitors(HIV protease inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC38H52N6O7 |
InChIKeyAXRYRYVKAWYZBR-ILCNTUBFSA-N |
CAS Registry1092540-56-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 1 | - | - | |
HIV Infections | Phase 1 | - | - |